Low scores on a cancer-recurrence gene test may allow breast cancer patients to skip chemotherapy


Albert Einstein College of Medicine


Joseph A. Sparano, MD, professor of medicine and of obstetrics and gynecology and women’s health at Albert Einstein College of Medicine, vice chairman of medical oncology at Montefiore Einstein Center for Cancer Care


The study illustrates how genetic information is transforming cancer care and could change the way breast cancer is currently treated.


Published in the New England Journal of Medicine in 2015